NCT04632732View on ClinicalTrials.gov

Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

COVID-19 test

Nasal pharyngeal swab

DIAGNOSTIC_TEST

Blood sampling

20cc of blood will be collected each 7 days during 28 days.

Trial Locations (1)

J1H5N4

Sherbrooke University, Sherbrooke

All Listed Sponsors
collaborator

University Hospital, Angers

OTHER_GOV

lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER

NCT04632732 - Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19). | Biotech Hunter | Biotech Hunter